Illumina Inc. Reports Q1 2025 Core Revenue of $1.04B, Down 1%; Non-GAAP EPS at $0.97

Reuters
2025/05/09
<a href="https://laohu8.com/S/ILMNV">Illumina Inc</a>. Reports Q1 2025 Core Revenue of $1.04B, Down 1%; Non-GAAP EPS at $0.97

Illumina Inc. has reported financial results for the first quarter of fiscal year 2025, revealing a slight dip in revenue and earnings compared to the same quarter last year. The company's core revenue for Q1 2025 stood at $1.041 billion, representing a 1% decrease from the $1.056 billion reported in Q1 2024. On a constant currency basis, revenue remained flat. The company reported a GAAP operating margin of 15.8% and a non-GAAP operating margin of 20.4% for the quarter. For Q1 2025, Illumina achieved a GAAP diluted EPS of $0.82 and a non-GAAP diluted EPS of $0.97. The company's cash provided by operations was $240 million, with a free cash flow of $208 million. Looking ahead to the fiscal year 2025, Illumina projects core revenue to decline by 1% to 3% on a constant currency basis, a revision from the previously anticipated low single-digit growth. Revenue outside of the Greater China region is expected to grow between 0% and 2% year over year on a constant currency basis. The company estimates reported revenue from the Greater China region will be between $165 million and $185 million for 2025, with $72 million recognized in Q1 2025. Additionally, Illumina anticipates $85 million in tariff-related costs, impacting the operating margin by an approximate 125 basis points and reducing EPS by $0.25 for the fiscal year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Illumina Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA83669) on May 08, 2025, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10